An interventional study of Use of the Chalaxie pedagogical evaluation tool in Pediatric Obesity, sponsored by Groupe Hospitalier de la Region de Mulhouse et Sud Alsace. Completed at 1 site in France. Open to participants aged 11 Years to 17 Years. Per ClinicalTrials.gov, last updated 2022-06-13.
Sponsored by Groupe Hospitalier de la Region de Mulhouse et Sud Alsace · Not applicable, Interventional, and Supportive care
The main objective of this study is to determine the benefit of the Chalaxie pedagogical evaluation tool in the management of overweight or obese children with intellectual disability.
Chalaxie is a software developped as a pedagogical evaluation tool. It is used in the therapeutic education of overweight and obese children and allow the clinican to explore several skills of the child, such as self-esteem.
Secondary objectives
Conduct of research After receiving written consent from the study participant and parental authority, the patients will have two visits with the pediatrician during which they will use the Chalaxie pedagogical evaluation tool. At the first visit, they will use the self-esteem assessment module. At the second visit (i.e. final visit), which should take place between 3 weeks and 2 months after the first visit, they will use a module of their choice.
363 studies on the registry are indexed under Intellectual Disability; 103 are open to participants now.
This study's enrollment of 29 is below the median of 53 across 236 interventional studies indexed under Intellectual Disability.
Browse Intellectual Disability studies →Groupe Hospitalier de la Region de Mulhouse et Sud Alsace is the lead sponsor of 27 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Procedure: Use of the Chalaxie pedagogical evaluation tool
Use of the Chalaxie pedagogical evaluation tool during two visits
Self-report patient perception questionnaire
The benefit of the Chalaxie pedagogical evaluation tool will be measured with the patient perception questionnaire completed at the final visit. It consists of seven single choice questions and one open question.
Time frame: through study completion, an average of 2 months
Duration of the visit
Duration will be measured from the moment the written consent is obtained until the end of the visit
Time frame: on enrollment day only
Duration of the use of the self-esteem assessment module
Duration will be measured from the moment the investigator clicks on the module until the completion of the last question.
Time frame: on enrollment day only
Clinician perception questionnaire
Clinician perception questionnaire consists of 12 single choice questions.
Time frame: Through study completion, on enrollment day to the final visit, an average of 2 months
Self-esteem
Self-esteem will be evaluated with the self-esteem assessment module. It consists of 6 questions with a visual scale of 6 emoticons. It also includes a 4-modality question assessing overall self-esteem that is completed by the patient and pediatrician respectively.
Time frame: on enrollment day only
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace